|No phase specified||Educational/Counseling/Training, Health services research||Completed||50 and over||NCI, Other||FCCC-05016|
CDR0000538413, IRB05-016, R01CA102695, 05-016, FCCC-IRB-05-016, NCT00459030
RATIONALE: Finding out which communication method affects a participant's decision to undergo colorectal cancer screening may help increase the number of participants who undergo screening. It is not yet known which communication method is more effective in increasing how often participants undergo colorectal cancer screening.
PURPOSE: This randomized clinical trial is studying traditional print communication methods to see how well they work compared with simple electronic communication methods or usual care in increasing how often older women undergo colorectal cancer screening.
Further Study Information
- Compare traditional print versus simple electronic communication versus usual care, in terms of increasing colorectal cancer (CRC) screening rates, in average-risk women attending a routine OB/Gyn visit.
- Explore the moderating role of attentional style and background variables on the impact of the interventions in these participants.
- Determine the mediating effect of potential cognitive-affective factors related to CRC screening in these participants.
- Investigate the comparative cost-effectiveness of these interventions to improve CRC screening adherence.
OUTLINE: This is a randomized study. Participants are randomized to 1 of 3 screening arms.
- Arm I: Participants are contacted by simple electronic communication methods by an email message linked to a personalized website.
- Arm II: Participants are contacted by traditional print communication methods.
- Arm III: Participants are observed (usual care). Participants in arms I and II are randomized a second time to receive messages about colorectal cancer screening that are matched or mismatched to their attentional style.
PROJECTED ACCRUAL: A total of 5,000 participants will be accrued for this study.
- At average risk for colorectal cancer (CRC) as defined by the following criteria:
- Asymptomatic without a personal history of colorectal polyps or cancer
- No inflammatory bowel disease
- No family history of familial adenomatous polyposis or hereditary nonpolyposis CRC
- No CRC in more than one first-degree relative
- Nonadherent with standard CRC screening recommendations at the time of index OB/Gyn appointment
- Email accessible at home and/or work
- Able to communicate with ease in English
PRIOR CONCURRENT THERAPY:
- Not specified
Trial Lead Organizations/Sponsors
Fox Chase Cancer Center - PhiladelphiaNational Cancer Institute
|David Weinberg||Study Chair|
Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00459030
ClinicalTrials.gov processed this data on October 17, 2013
Back to Top